快而精医药(QGEN)

49.26 -1.09 -2.16%

今开:49.31昨收:50.35
最高:49.61 最低:49.15
涨停价:0.0跌停价:0.0
总市值:1.1216502E10

快而精医药的热门评论

财报披露

快而精医药(QGEN)02-10 05:48

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000002 Act: 34 Size: 589 KB 网页链接查看全文

超过5%股东持股披露「修订」

快而精医药(QGEN)01-28 03:06

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-002390 Act: 34 Size: 13 KB 网页链接查看全文

超过5%股东持股披露「修订」

快而精医药(QGEN)02-03 01:51

$快而精医药(QGEN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000912938-22-000228 Act: 34 Size: 17 KB 网页链接查看全文

超过5%股东持股披露

快而精医药(QGEN)01-26 19:12

$快而精医药(QGEN)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-000836 Act: 34 Size: 13 KB 网页链接查看全文

牛股小红书01-08 11:12

$快而精医药(QGEN)$ 宣布公司的数字PCR平台QIAcuity上,新增加的应用程序也越来越多。
该公司已开展了两项新的合作,以扩展QIAcuity生态系统:
1、与Atila BioSystems合作,为QGEN的dPCR特许经营权提供无创产前检测(NIPT)解决方案。NIPT只需要从母亲那里采集血液样本,并取代了更具侵入...查看全文

财报披露

快而精医药(QGEN)2021-11-08 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000054 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)2021-11-08 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000051 Act: 34 Size: 582 KB 网页链接查看全文

chuminhua2020-08-15 21:30

8/13,Qiagen$快而精医药(QGEN)$ 的投资者拒绝了Thermo Fisher$赛默飞世尔科技(TMO)$ 数十亿美元的收购提议。两家公司在3月达成115亿美元的收购交易,因COVID-19疫情,收购价于7月又提升至125亿美元。但还是不够,股东们认为,疫情的规模和持续证明了分子诊断日益重要,公司已经制定了将试剂产量翻...查看全文

美股滚雪球2020-08-03 09:21

西门子并购$瓦里安医疗系统(VAR)$ :164亿美元,这是今年迄今为止最大的并购,超过了$赛默飞世尔科技(TMO)$ 以125亿美元并购$快而精医药(QGEN)$查看全文

财报披露

快而精医药(QGEN)2021-08-02 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000046 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

专项披露公告

快而精医药(QGEN)06-01 18:06

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

快而精医药(QGEN)04-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)04-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接查看全文

定期披露文件

快而精医药(QGEN)03-14 19:36

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接查看全文

年度财报

快而精医药(QGEN)03-14 19:27

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30